Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
In a pioneering Phase 1 clinical trial at UCI Health in California, medical researchers have utilized a targeted laser technique combined with the photosensitive drug padeliporfin to destroy blood vessels ... Read More
Continuous Coverage
Major artificial intelligence firms, including OpenAI and Anthropic, are investigating tens of thousands of security incidents involving advanced…
Broadcaster Monty Don announced he is stepping down from Gardeners’ World after 23 years, revealing that his departure…
British counter-terrorism police arrested multiple men on suspicion of explosive offenses near RAF Fairford in Gloucestershire on Sunday,…
Reports surrounding a high-stakes diplomatic exchange during the United Nations General Assembly in New York have sparked friction…
The Wyoming Cowboys opened their Mountain West Conference schedule with a 27-10 victory over Hawai’i, successfully retaining the…
On September 27, People Power Party leader Jang Dong-hyuk ignited a fierce political storm during a National Assembly…
Global Affairs
On September 27, 2026, Northern Ireland Secretary Chris Bryant stated that a court ruling permitting the Orange Order…
Markets And Money
General Motors brand Cadillac (NYSE: GM) is exiting its 600-square-meter showroom on Zurich’s Bahnhofstrasse after just three years,…
Digital Culture
Millions of living rooms are acting as passive data farms, with popular smart television platforms logging everything from…
Science And Wellbeing
Yoga inversions—such as Sirsasana (Headstand) and Sarvangasana (Shoulderstand)—elevate the heart above the head to improve circulation, build core…
Screen And Sound
Alexander Zeldin’s The Other Place, After Antigone at the Théâtre de la Ville-Sarah Bernhardt, Aurélia Lüscher and Estelle…
Fixtures And Form
Roger Federer confessed in September 2026 that he still misses the daily routine of the tour, admitting he…
